3rd Obesity and Weight Loss Drug Development Summit

The 3rd Obesity and Weight Loss Drug Development Summit focuses on novel targets and GLP combination therapies to develop more effective, tolerable, and personalized solutions for long-lasting weight management outcomes.

Topics

• Potential of novel targets in weight loss treatment
• Strategies for personalized patient treatment
• GLP combination therapies to manage side effects
• Insights from pharmaceutical leaders and innovative biotechs
• Evaluation of the obesity landscape
• Collaborative opportunities for obesity scientists and drug development experts

Who should Attend

• Obesity scientists
• Drug development experts
• Pharmaceutical professionals
• Healthcare researchers
• Biotech innovators